WOLVERINE ASSET MANAGEMENT LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$116
-12.8%
3000.0%0.00%
Q2 2023$133
-45.9%
3000.0%0.00%
Q1 2023$246
-99.8%
300
-99.7%
0.00%
-100.0%
Q4 2022$156,468
-9.6%
100,3000.0%0.00%0.0%
Q3 2022$173,0000.0%100,3000.0%0.00%0.0%
Q2 2022$173,000
-51.9%
100,3000.0%0.00%
-50.0%
Q1 2022$360,000
-36.1%
100,300
-11.2%
0.00%
-20.0%
Q4 2021$563,000
-30.4%
113,0000.0%0.01%
-28.6%
Q3 2021$809,000
+373.1%
113,000
+510.8%
0.01%
+600.0%
Q2 2021$171,0000.0%18,5000.0%0.00%0.0%
Q1 2021$171,000
+48.7%
18,500
+42.3%
0.00%0.0%
Q4 2020$115,000
+88.5%
13,000
+141.0%
0.00%
Q3 2020$61,000
-84.5%
5,394
-63.1%
0.00%
-100.0%
Q2 2020$393,000
+222.1%
14,600
-11.0%
0.00%
+100.0%
Q1 2020$122,000
+103.3%
16,400
-10.9%
0.00%
+100.0%
Q4 2019$60,000
+328.6%
18,400
+155.6%
0.00%
Q3 2019$14,000
-85.9%
7,200
-78.8%
0.00%
-100.0%
Q2 2019$99,000
-21.4%
34,0000.0%0.00%
-50.0%
Q1 2019$126,00034,0000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DC Investments Management, LLC 82,696$959,0001.05%
Defender Capital, LLC. 119,914$1,391,0000.68%
Bayesian Capital Management, LP 171,200$1,986,0000.48%
Enlightenment Research, LLC 13,800$160,0000.47%
Harvest Investment Services, LLC 47,558$551,0000.32%
WASATCH ADVISORS LP 3,383,001$39,243,0000.25%
Cedar Brook Financial Partners, LLC 54,900$637,0000.25%
Monaco Asset Management SAM 33,900$393,0000.23%
Coatue Management 3,576,923$41,492,0000.22%
SABBY MANAGEMENT, LLC 124,884$1,449,0000.22%
View complete list of INOVIO PHARMACEUTICALS INC shareholders